Atosiban vs ritodrine used prophylactically with cerclage in ICSI pregnancies to prevent pre-term birth in women identified as being at high risk on the basis of transvaginal ultrasound scan
Autor: | M. Miranda, Giovanni Nazzaro, M. L. Pisaturo, G. De Placido, A. Merenda, Mariavittoria Locci, P. Laviscio, R. Poppiti, A. Stile |
---|---|
Přispěvatelé: | Locci, M., Nazzaro, G., Merenda, A., Pisaturo, M., Laviscio, P., Poppiti, R., Miranda, M., Stile, A., De Placido, G., Locci, Mariavittoria, Nazzaro, G, Merenda, A, Pisaturo, Ml, Laviscio, P, Poppiti, R, Miranda, M, Stile, A, DE PLACIDO, Giuseppe |
Rok vydání: | 2006 |
Předmět: |
Adult
medicine.medical_treatment Ritodrine Hydrochloride Ultrasonography Prenatal Obstetric Labor Premature Vasotocin Risk Factors Pregnancy Tocolytic Agent medicine Humans Rupture of membranes Cervical cerclage Sperm Injections Intracytoplasmic Cerclage Cervical business.industry Risk Factor Infant Newborn Pregnancy Outcome Obstetrics and Gynecology Gestational age Atosiban Low birth weight Tocolytic Agents Ritodrine Anesthesia Term Birth Female Pregnancy Multiple medicine.symptom business Human medicine.drug |
Zdroj: | Journal of Obstetrics and Gynaecology. 26:396-401 |
ISSN: | 1364-6893 0144-3615 |
DOI: | 10.1080/01443610600719883 |
Popis: | Our objective was to compare the effectiveness and safety of atosiban and ritodrine, in pregnancies obtained by intracytoplasmic sperm injection (ICSI) undergoing cervical cerclage. Data from a prospective study were compared with those from a retrospective study. Sixteen ICSI pregnant women, 20 - 24 weeks' gestation and maternal age >18 years, received atosiban (bolus dose 6.75 mg i.v., followed by 300 μg/min i.v. for 3 h and 100 μg/min i.v. for 45 h). Cervical cerclage was performed 3 h after starting atosiban. The control group (group B) of 16 ICSI pregnant women were matched and received ritodrine hydrochloride (100 - 350 μg/min) for 48 h. Cervical cerclage was performed after 24 h. Pre-term rupture of membranes occurred within 48 h of cervical cerclage in one woman receiving atosiban and in four women receiving ritodrine. There was no significant difference in terms of pregnancies not delivered at 48 h (short-term tocolysis) and at 7 days (long-term tocolysis). However, there was a significantly higher incidence of maternal tachycardia with ritodrine compared with atosiban (p |
Databáze: | OpenAIRE |
Externí odkaz: |